Medical Care
The goal of therapy for achalasia is to relieve symptoms by eliminating the outflow resistance caused by the hypertensive and nonrelaxing LES. Once the obstruction is relieved, the food bolus can travel through the aperistaltic body of the esophagus by gravity.
- Calcium channel blockers and nitrates are used to decrease LES pressure.
- Approximately 10% of patients benefit from this treatment.
- This treatment is used primarily in elderly patients who have contraindications to either pneumatic dilatation or surgery.
- Endoscopic treatment includes an intrasphincteric injection of botulinum toxin to block the release of acetylcholine at the level of the LES, thereby restoring the balance between excitatory and inhibitory neurotransmitters.[3]
- This treatment has limited value. Only 30% of patients treated endoscopically still have relief of dysphagia 1 year after treatment.
- This treatment can cause an inflammatory reaction at the level of the gastroesophageal junction, making a subsequent myotomy very difficult.
- Use this treatment in elderly patients who are poor candidates for dilatation or surgery.
- Pneumatic dilatation performed by a qualified gastroenterologist is the recommended treatment in those sporadic cases in which surgery is not appropriate.[4]
- A balloon is inflated at the level of the gastroesophageal junction to blindly rupture the muscle fibers while leaving the mucosa intact.
- The success rate is 70-80%, and the perforation rate is approximately 5%.
- If a perforation occurs, emergency surgery is needed to close the perforation and to perform a myotomy.
- As many as 50% of patients may require more than 1 dilatation.
- The incidence of abnormal gastroesophageal reflux after the procedure is approximately 25%.
- A laparoscopic Heller myotomy is considered by many to be the appropriate primary treatment of patients with achalasia (see Surgical Care). A Heller myotomy and a partial fundoplication performed from the chest (thoracoscopic) have a high incidence of gastroesophageal reflux.[4, 5, 6]
Surgical Care
Because of excellent results, a short hospital stay, and a fast recovery time, the primary treatment is considered by many to be a laparoscopic Heller myotomy and partial fundoplication.[5, 4] In the author's experience and in the experience of many authors, this treatment provides a fine balance in relieving symptoms of dysphagia by performing the myotomy and in preventing gastroesophageal reflux by adding a partial wrap. A prospective, randomized study from Vanderbilt University indicated that there is significantly less risk of postoperative reflux following a Heller myotomy plus a partial fundoplication than there is after a Heller myotomy alone.[7] The authors of this study also showed that in patients with achalasia, adding a partial fundoplication not only is more effective in preventing postoperative reflux but also is more cost-effective at a time horizon of 10 years.[8]
However, the use of preoperative endoscopic therapy remains common but has resulted in intraoperative complications (eg, esophageal perforation) and postoperative complications and in a high failure rate.
- Minimally invasive surgery for achalasia is performed under general anesthesia with the use of 5 trocars. A controlled division of the muscle fibers (myotomy) of the lower esophagus (5 cm) and the proximal stomach (1.5 cm) is carried out, followed by a partial fundoplication to prevent reflux. See the images below.
Heller myotomy extending 1.5 cm onto the gastric wall.
Dor fundoplication, left row of sutures (after division of short gastric vessels).
Completed Dor fundoplication. - Patients remain hospitalized for 24-48 hours and return to regular activities in about 2 weeks.
- The operation relieves symptoms in 85-95% of patients, and the incidence of postoperative reflux is 10-15%.
- For patients in whom surgery fails, they may be treated with an endoscopic dilatation first. If this fails, a second operation (extending the previous myotomy onto the anterior gastric wall) can be attempted once the cause of failure has been identified with imaging studies. The last resort is to surgically remove the esophagus (ie, esophagectomy).
- Treatment options vary for patients with different degrees of illness severity. A study by Reynoso et al suggests that among hospitalized patients with minor/moderate illness severity, laparoscopic myotomy for achalasia showed comparable or better outcomes than esophageal dilation.[9] Laparoscopic myotomy is not associated with superior success rates for patients with newly diagnosed achalasia.[10] For major/extreme illness severity, dilation showed comparable or better profile for hospitalized patients with achalasia.
Esophagectomy was the standard treatment in patients with achalasia and a markedly dilated or sigmoid-shaped esophagus, with Heller myotomy considered to be ineffective in such cases. However, in a study by Sweet and colleagues of 113 patients with achalasia, the investigators reported that (1) in most of the study's patients, even those with achalasia and a dilated esophagus, a laparoscopic Heller myotomy relieved dysphagia; (2) additional treatment was needed in about 20% of patients; and (3) in the end, 90% of patients had attained good swallowing ability. Esophagectomy was not required in any of the patients to maintain clinically adequate swallowing.[11]
Cowgill et al reported on outcomes in 47 patients more than 10 years after they had undergone laparoscopic Heller myotomy for achalasia.[6] The investigators found that notable complications were infrequent following the procedure and that no perioperative deaths had occurred. One patient underwent a second myotomy 5 years after the first, because of symptom recurrence.
There were 33 surviving patients at the time of the study; the authors reported that the other patients died from causes that were unrelated to myotomy. Using a Likert scale and a Wilcoxon matched-pairs test to assess patients’ symptoms before and after laparoscopic myotomy, Cowgill and colleagues found significant postsurgery decreases in the frequency and severity scores for dysphagia, chest pain, vomiting, regurgitation, choking, and heartburn. They concluded that "[t]he symptoms of achalasia are durably ameliorated by laparoscopic Heller myotomy during long-term follow-up evaluation."
Ferri LE, Cools-Lartigue J, Cao J, Miller L, Mayrand S, Fried GM, et al. Clinical predictors of achalasia. Dis Esophagus. Aug 28 2009;[Medline].
Ayazi S, Crookes PF. High-resolution esophageal manometry: using technical advances for clinical advantages. J Gastrointest Surg. Sep 18 2009;[Medline].
Kroupa R, Hep A, Dolina J, Valek V, Matyasova Z, Prokesova J, et al. Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. Dis Esophagus. Aug 28 2009;[Medline].
Pastor AC, Mills J, Marcon MA, Himidan S, Kim PC. A single center 26-year experience with treatment of esophageal achalasia: is there an optimal method?. J Pediatr Surg. Jul 2009;44(7):1349-54. [Medline].
Eckardt AJ, Eckardt VF. Current clinical approach to achalasia. World J Gastroenterol. Aug 28 2009;15(32):3969-75. [Medline]. [Full Text].
Cowgill SM, Villadolid D, Boyle R, Al-Saadi S, Ross S, Rosemurgy AS 2nd. Laparoscopic Heller myotomy for achalasia: results after 10 years. Surg Endosc. Jun 24 2009;[Medline].
Richards WO, Torquati A, Holzman MD, Khaitan L, Byrne D, Lutfi R, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg. Sep 2004;240(3):405-12; discussion 412-5. [Medline].
Torquati A, Lutfi R, Khaitan L, Sharp KW, Richards WO. Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial. Surg Endosc. Mar 2006;20(3):389-93. [Medline].
Reynoso JF, Tiwari MM, Tsang AW, Oleynikov D. Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia. Surg Endosc. May 2011;25(5):1466-71. [Medline].
Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. May 12 2011;364(19):1807-16. [Medline].
Sweet MP, Nipomnick I, Gasper WJ, Bagatelos K, Ostroff JW, Fisichella PM, et al. The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation. J Gastrointest Surg. Jan 2008;12(1):159-65. [Medline].
Abid S, Champion G, Richter JE, McElvein R, Slaughter RL, Koehler RE. Treatment of achalasia: the best of both worlds. Am J Gastroenterol. Jul 1994;89(7):979-85. [Medline].
Benini L, Sembenini C, Castellani G, Bardelli E, Brentegani MT, Giorgetti P, et al. Pathological esophageal acidification and pneumatic dilitation in achalasic patients. Too much or not enough?. Dig Dis Sci. Feb 1996;41(2):365-71. [Medline].
Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology. Nov 1982;83(5):963-9. [Medline].
Hunter JG, Trus TL, Branum GD, Waring JP. Laparoscopic Heller myotomy and fundoplication for achalasia. Ann Surg. Jun 1997;225(6):655-64; discussion 664-5. [Medline].
Katz PO, Gilbert J, Castell DO. Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci. Sep 1998;43(9):1973-7. [Medline].
Moonka R, Patti MG, Feo CV, Arcerito M, De Pinto M, Horgan S, et al. Clinical presentation and evaluation of malignant pseudoachalasia. J Gastrointest Surg. Sep-Oct 1999;3(5):456-61. [Medline].
Patti MG, Arcerito M, Tong J, De Pinto M, de Bellis M, Wang A, et al. Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia. J Gastrointest Surg. Nov-Dec 1997;1(6):505-10. [Medline].
Patti MG, Feo CV, Arcerito M, De Pinto M, Tamburini A, Diener U, et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci. Nov 1999;44(11):2270-6. [Medline].
Patti MG, Fisichella PM, Perretta S, Galvani C, Gorodner MV, Robinson T, et al. Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change. J Am Coll Surg. May 2003;196(5):698-703; discussion 703-5. [Medline].
Patti MG, Pellegrini CA, Arcerito M, Tong J, Mulvihill SJ, Way LW. Comparison of medical and minimally invasive surgical therapy for primary esophageal motility disorders. Arch Surg. Jun 1995;130(6):609-15; discussion 615-6. [Medline].
Smith CD, Stival A, Howell DL, Swafford V. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone. Ann Surg. May 2006;243(5):579-84; discussion 584-6. [Medline].
Spiess AE, Kahrilas PJ. Treating achalasia: from whalebone to laparoscope. JAMA. Aug 19 1998;280(7):638-42. [Medline].
Stewart KC, Finley RJ, Clifton JC, Graham AJ, Storseth C, Inculet R. Thoracoscopic versus laparoscopic modified Heller Myotomy for achalasia: efficacy and safety in 87 patients. J Am Coll Surg. Aug 1999;189(2):164-9; discussion 169-70. [Medline].
Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. Feb 1999;44(2):231-9. [Medline].
Woltman TA, Oelschlager BK, Pellegrini CA. Surgical management of esophageal motility disorders. J Surg Res. Mar 2004;117(1):34-43. [Medline].
Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg. Mar 2004;239(3):364-70. [Medline].

